Tarsus Pharma Partners With LianBio For TP-03 In Greater China For Eye Diseases
Here's Why Ophthotech Is Trading Down On Regeneron's News
Aerie Pharmaceuticals Announces Initiation Of Second Phase 3 Trial For Roclatan
Eyegate Pharmaceuticals Spikes 12%; Co. Eligible To Receive Milestone Payment From Valeant